Regenerative Medicine and Stem Cells Technologies

The president of the fifth symposium on genetics and stem cells with a gene therapy approach regarded this area as one of the fields that have had suitable improvements with the help of the researchers of the country.

In a stunning piece of research, Stanford neuroscientists have hunted down a single gene that encodes a protein responsible for age-related cognitive losses, targeted it with special blocking antibodies, and shown in mice that these antibodies can rejuvenate old brains to work as well as young ones.

A new technique using patients own modified cells to treat Crohns disease has been proven to be effective in experiments using human cells, with a clinical trial of the treatment expected to start in the next six months.

Bioscientists are moving closer to 3D-printed artificial tissues to help heal bone and cartilage typically damaged in sports-related injuries to knees, ankles and elbows.

The University of Minnesota Medical School continues its legacy of advancing cell replacement therapies with a scientific breakthrough that highlights the promise of cell therapies for muscular dystrophy.

Emergency room doctors often have only a few minutes to determine which patients are in need of a blood transfusion.

Some of the damaging cell effects linked to ageing could be prevented by manipulating tiny parts of cells, a study shows.

Most human cells have 23 pairs of chromosomes. Any deviation from this number can be fatal for cells, and several genetic disorders, such as Down syndrome, are caused by abnormal numbers of chromosomes.

Yet spermatogonial stem cells have not been well studied in humans, and attempts to grow them in the lab for clinical purposes have had limited success.

Children living with a rare muscle-wasting condition will now benefit from a new drug.